reference/3210720

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3210720

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	174
issn	1078-0432 1557-3265
issueIdentifier	1
pageRange	166-174
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	166
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6b9463c19ffd4aea77b56c72a452efd0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_393774af197b696160b1583a281e649b
bibliographicCitation	Katayama R, Kobayashi Y, Friboulet L, Lockerman EL, Koike S, Shaw AT, Engelman JA, Fujita N. Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer. Clin Cancer Res. 2015 Jan 01;21(1):166–74. PMID: 25351743; PMCID: PMC4286456.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24fcc8f37da4027890b6e9ef8b21b4f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9631-9264 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d85c7c3f016d868000fc75528d1801f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_990d93baa910ea000185456b8d8b56a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ef8696a91ca64588e99f0546b64cb48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e49790477009dcf65772ab641660bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7394-895X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a2be942681374e967b264372b88f6f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f60bd15606b7ccb350c0ca64e069e92a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_516e2e92958895fd6a2a3fb492743385
date	2015-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25351743 https://pubmed.ncbi.nlm.nih.gov/PMC4286456 https://doi.org/10.1158/1078-0432.ccr-14-1385
isPartOf	https://portal.issn.org/resource/ISSN/1557-3265 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer
discusses	http://id.nlm.nih.gov/mesh/M0001420 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0001412 http://id.nlm.nih.gov/mesh/M0172583 http://id.nlm.nih.gov/mesh/M0131295 http://id.nlm.nih.gov/mesh/M0558240 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0001214 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0017888
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011725Q000008 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000813Q000008 http://id.nlm.nih.gov/mesh/D019008Q000187 http://id.nlm.nih.gov/mesh/D011505Q000096 http://id.nlm.nih.gov/mesh/D011518Q000096
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000949Q000235 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D000944Q000235 http://id.nlm.nih.gov/mesh/D000949Q000096 http://id.nlm.nih.gov/mesh/D011518Q000235 http://id.nlm.nih.gov/mesh/D000944Q000096 http://id.nlm.nih.gov/mesh/D015514Q000235 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000077547 http://id.nlm.nih.gov/mesh/D011720Q000008 http://id.nlm.nih.gov/mesh/D011505Q000235 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D047428Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_409284776abdc514ad658882279be467 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25102847 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4e826c880e43b7ad8008a5acf74ab07b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12967 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6098

Total number of triples: 79.